Home

Shawn mcCormick

CIK 1454092 · Chief Financial Officer · last filed 2026-05-11

Shawn mcCormick is a Chief Financial Officer who has filed 70 SEC Form 4 insider transactions across 7 companies since 2009. The most recent filing shows the insider sold $31.5K of INSP on May 11, 2026. Across all open-market trades the lifetime net is −$885.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions. 13 SEC filings were submitted jointly with Wright Medical Group N.V.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.04M

Companies

7

Total Filings

70

Lifetime Open-Market Net

-$885.0K

Filer Profile

Reported Address
9600-54TH AVENUE NORTH
SUITE 100
PLYMOUTH, MN 55441
Related Filers
Wright Medical Group N.V. — 13 joint filings, latest 2015-10-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INSP Director 30,712 $66.48 $2.04M -$638.9K 17 2026-05-11
NEVRO CORP (NVRO) Delisted Director 0 $5.84 $0 -$113.0K 15 2025-04-03
SURMODICS INC (SRDX) Delisted Director 9,210 $42.98 $395.8K $0 13 2020-02-18
ENTL Director 0 $7.41 $0 $50.0K 4 2018-03-01
Wright Medical Group N.V. (WMGI.Z) Delisted Chief Financial Officer 36,034 — — $0 1 2015-10-05
Wright Medical Group N.V. (TRNX) Delisted Chief Financial Officer 3 — — -$117.1K 10 2015-06-05
ev3 Inc. (EVVV) Delisted Senior VP and CFO 0 — — -$66.1K 5 2010-07-13

Recent Filings

70 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-11 INSP Sell (S) −696 -$31.5K EDGAR
2026-05-08 INSP Notice (144) −696 -$31.7K EDGAR
2026-05-04 INSP Grant (A) +3,562 $0 EDGAR
2025-12-04 INSP Sell (S) −1,200 -$166.8K EDGAR
2025-12-02 INSP Notice (144) −1,200 -$151.6K EDGAR
2025-12-01 INSP Sell (S) −2,000 -$255.0K EDGAR
2025-11-28 INSP Notice (144) −2,000 -$254.7K EDGAR
2025-06-06 INSP Exer (M) +4,000 $64.0K EDGAR
2025-05-05 INSP Mixed +906 -$57.6K EDGAR
2025-05-02 INSP Notice (144) −360 -$56.8K EDGAR
Showing 1–10 of 70
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.